Acetylaconitine
CAS No. 77181-26-1
Acetylaconitine( Acetylaconitine | 3-Acetylaconitine )
Catalog No. M19096 CAS No. 77181-26-1
Analgesic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 58 | In Stock |
|
| 10MG | 98 | In Stock |
|
| 25MG | 167 | In Stock |
|
| 50MG | 250 | In Stock |
|
| 100MG | 376 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAcetylaconitine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnalgesic activity.
-
DescriptionAnalgesic activity.
-
In VitroFlaconitine has been demonstrated to suppress TNF-α induced NF-κB activation and is considered as a diester-diterpenoid-type NF-κB inhibitor Flaconitine (3-Acetylaconitine)is evaluated for its cytotoxic activity against human leukemic P388 cells using the SRB (Sulforhodamine B) method, with Etoposide as the positive control. The cell growth inhibitory potency of Flaconitine is expressed as IC50 (μM) Value. Flaconitine exhibits moderately cytotoxic activity with an IC50 of 18.6 μM.
-
In Vivo——
-
SynonymsAcetylaconitine | 3-Acetylaconitine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number77181-26-1
-
Formula Weight687.77
-
Molecular FormulaC36H49NO12
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (72.70 mM)
-
SMILESCCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)OC(=O)C)OC)OC)OC(=O)C)COC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Miricorilant
Miricorilant (CORT 118335) is a selective glucocorticoid receptor modulator for the study of digestive and metabolic disorders.
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
-
Ketohexokinase inhib...
Ketohexokinase inhibitor 1 is a ketohexokinase inhibitor.
Cart
sales@molnova.com